| Property | Value |
|---|---|
| Category | Glymphatic System/Astrocyte Biomarker |
| Target | Aquaporin-4 water channel |
| Sample Type | Brain tissue, CSF (limited), plasma (experimental) |
| Diseases | Alzheimer's Disease, Parkinson's Disease, Stroke, Traumatic Brain Injury, Normal Pressure Hydrocephalus |
| Role | Water homeostasis, glymphatic clearance, astrocyte function |
Aquaporin-4 (AQP4) is a water channel protein primarily expressed in astrocytic end-feet that surround cerebral blood vessels and the pial surface. It is the main water channel in the brain and plays a critical role in brain water balance, cerebrospinal fluid circulation, and the glymphatic system[1].
AQP4 exists in two isoforms:
The protein is densely packed in astrocytic end-feet membranes that ensheath cerebral blood vessels, forming the anatomical basis for the glymphatic system.
The glymphatic system is a brain-wide waste clearance pathway that operates primarily during sleep:
| Method | Advantages | Limitations |
|---|---|---|
| Immunohistochemistry | Gold standard for brain tissue | Requires biopsy/autopsy |
| Western Blot | Quantifies protein expression | Semi-quantitative |
| MRI with gadolinium | Functional glymphatic imaging | Invasive |
| Diffusion MRI | Glymphatic flow assessment | Indirect measure |
| CSF AQP4 | Minimally invasive | Limited sensitivity |
| Plasma AQP4 | Easy sampling | Experimental |
| Agent | Target | Phase | Status |
|---|---|---|---|
| TGN-020 | AQP4 inhibitor | Preclinical | Research |
| Bromocriptine | AQP4 modulation | Phase 2 | Ongoing |
Aquaporin-4 is a critical component of the glymphatic system and represents a promising biomarker for assessing brain waste clearance function. While direct measurement in living patients remains challenging, advances in imaging and fluid biomarkers are enabling better characterization of AQP4 dysfunction in neurodegenerative diseases. Targeting AQP4 and the glymphatic system represents a novel therapeutic approach for enhancing the clearance of neurotoxic proteins in AD, PD, and other neurodegenerative conditions.
The study of Aquaporin 4 (Aqp4) Glymphatic System Biomarker has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Iliff JJ, et al. "Brain-wide glymphatic pathway for the clearance of interstitial waste." Sci Transl Med. 2013;5(215):215ra173. 2013. ↩︎
Yang J, et al. "Aquaporin-4 and Alzheimer's disease." J Alzheimers Dis. 2021;80(1):11-25. 2021. ↩︎
Zhang J, et al. "Aquaporin-4 deficiency in Parkinson's disease brain." Neurobiol Aging. 2019;78:102-111. 2019. ↩︎
Li L, et al. "Aquaporin-4 in traumatic brain injury." J Neurotrauma. 2019;36(7):1041-1052. 2019. ↩︎
Xie L, et al. "Sleep drives metabolite clearance from the adult brain." Science. 2013;342(6156):373-377. 2013. ↩︎
Kress BT, et al. "Impairment of paravascular clearance in aged mice." Ann Neurol. 2014;76(5):845-857. 2014. ↩︎